SI1581227T1 - Metoda za zdravljenje odpovedi ledvic - Google Patents

Metoda za zdravljenje odpovedi ledvic

Info

Publication number
SI1581227T1
SI1581227T1 SI200430232T SI200430232T SI1581227T1 SI 1581227 T1 SI1581227 T1 SI 1581227T1 SI 200430232 T SI200430232 T SI 200430232T SI 200430232 T SI200430232 T SI 200430232T SI 1581227 T1 SI1581227 T1 SI 1581227T1
Authority
SI
Slovenia
Prior art keywords
renal failure
treating renal
treatment
failure
treating
Prior art date
Application number
SI200430232T
Other languages
English (en)
Inventor
Matti Kivikko
Heimo Haikala
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of SI1581227T1 publication Critical patent/SI1581227T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
SI200430232T 2003-01-03 2004-01-02 Metoda za zdravljenje odpovedi ledvic SI1581227T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20030015A FI20030015A0 (fi) 2003-01-03 2003-01-03 Menetelmä munuaisten vajaatoiminnan hoitamiseksi
PCT/FI2004/000002 WO2004060375A1 (en) 2003-01-03 2004-01-02 A method for treating renal failure
EP04700048A EP1581227B1 (en) 2003-01-03 2004-01-02 A method for treating renal failure

Publications (1)

Publication Number Publication Date
SI1581227T1 true SI1581227T1 (sl) 2007-06-30

Family

ID=8565258

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200430232T SI1581227T1 (sl) 2003-01-03 2004-01-02 Metoda za zdravljenje odpovedi ledvic

Country Status (13)

Country Link
US (1) US20060166994A1 (sl)
EP (1) EP1581227B1 (sl)
JP (1) JP4588016B2 (sl)
AT (1) ATE355063T1 (sl)
CA (1) CA2511735C (sl)
CY (1) CY1106586T1 (sl)
DE (1) DE602004005000T2 (sl)
DK (1) DK1581227T3 (sl)
ES (1) ES2281775T3 (sl)
FI (1) FI20030015A0 (sl)
PT (1) PT1581227E (sl)
SI (1) SI1581227T1 (sl)
WO (1) WO2004060375A1 (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004270161A1 (en) 2003-08-28 2005-03-17 Nicox S.A. Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
FI20040674A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
AU2006216665A1 (en) 2005-02-24 2006-08-31 Nicox S.A. Nitric oxide enhancing diuretic compounds, compositions and methods of use
EP3993773A1 (en) 2019-07-01 2022-05-11 Orion Corporation Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
JP3131845B2 (ja) * 1991-06-12 2001-02-05 帝国臓器製薬株式会社 慢性心不全治療剤
ATE327751T1 (de) * 2000-01-31 2006-06-15 Pfizer Prod Inc Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz

Also Published As

Publication number Publication date
DE602004005000D1 (de) 2007-04-12
FI20030015A0 (fi) 2003-01-03
CY1106586T1 (el) 2012-01-25
WO2004060375A1 (en) 2004-07-22
EP1581227B1 (en) 2007-02-28
ATE355063T1 (de) 2006-03-15
CA2511735C (en) 2011-09-20
EP1581227A1 (en) 2005-10-05
DE602004005000T2 (de) 2007-11-15
JP4588016B2 (ja) 2010-11-24
CA2511735A1 (en) 2004-07-22
DK1581227T3 (da) 2007-04-23
JP2006515348A (ja) 2006-05-25
PT1581227E (pt) 2007-03-30
US20060166994A1 (en) 2006-07-27
ES2281775T3 (es) 2007-10-01

Similar Documents

Publication Publication Date Title
MXPA05013773A (es) Metodo para elaborar carboxialquilcelulosa.
IL147618A0 (en) Method for treating chronic pain using mek inhibitors
GB0505388D0 (en) Linking component, system, and method for providing additional services at a conventional gaming machine
MX2007007723A (es) Un biomaterial implantable y un metodo para producirlo.
EP2085086A3 (en) Method for treating congestive heart failure or diabetic nephropathy
ZA200305204B (en) Gaming machine, program, and server.
WO2006055981A3 (en) Use of cutured three-dimensional tissue for treating congestive heart failure
ZA200208001B (en) Game server, game control method, and game machine.
ZA200208419B (en) Game machine, game server, and game control method.
WO2005000095A3 (en) Isoforms of brain natriuretic peptide
ZA200208078B (en) Game server, game machine, game control server, and game control method.
AU2003239219A1 (en) Method for treating congestive heart failure using external counterpulsation
WO2007053284A3 (en) Method of treating breast cancer using 17-aag or 17-ag or a prodrug of either in combination with a her2 inhibitor
TW200616639A (en) Methods for treating a mammal before, during and after cardiac arrest
NZ516619A (en) Phosphate transport inhibitors
WO2009024947A3 (en) Device for dialysis and stimulation of a patient and method
HK1064261A1 (en) Method for the treatment of tobacco.
ZA200502307B (en) Method for treating patients with massive blood loss
SI1581227T1 (sl) Metoda za zdravljenje odpovedi ledvic
UA83203C2 (uk) Тіазол-(бі)циклоалкілкарбоксаніліди, засіб на їх основі та застосування для боротьби з небажаними мікроорганізмами
TW200618799A (en) Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof
ZA200308099B (en) Gaming machine, server, and program.
IS7705A (is) 4-(3,5-Dísýanófenoxý) pýrasól afleiður til notkunar sem bakritunarstillar við meðhöndlun á m.a. eyðniveirunni
WO2006116300A3 (en) Methods of treating graft versus host disease
ZA200309752B (en) System, server and method for integrated management of casino and hotel.